What You Know Can Change Lives
The GBS|CIDP Foundation is dedicated to being a resource for all those dealing with the disorder, including healthcare professionals. The industry, along with the Foundation, publish documents that help inform medical professionals.
In 2014, the GBS|CIDP Foundation International awarded 4 research grants.
- Researchers led by Dr. Isabel Illa at Hospital Santa Creu-Sant Pau in Barcelona, Spain, are looking to identify different genetic subgroups of CIDP. Once identified, these subgroups will enable doctors to introduce more specific therapies and prognoses to patients, specifically for IVIg and steroid-resistant patients.
- Proper treatment for GBS in low-income countries is severely lacking, leading to mortality and disability rates far higher than those reported in America and European countries. In Bangladesh, where the incidence rate for GBS is much higher than the global average, Dr. Zhahirul Islam and his team are working on developing new outcome measures for GBS patients in low-income countries.
- At the University of Chicago, Dr. Betty Soliven is investigating how different types of immune cells contribute to disease severity in CIDP patients. This research explore the regulatory mechanisms involved in CIDP, and could lead to new therapeutic strategies.
- In many cases, incomplete recovery from GBS symptoms is caused by the failure of the peripheral nervous system to regenerate. Dr. Pablo H. H. Lopez in Argentina is attempting to better understand the signaling pathway involved in neuron grown inhibition.
The Foundation awarded the first Benson Fellowship in 2014.
- Ruth Huizinga aims to understand how preceding infections cause the development of anti-neuronal antibodies. She is working in the lab of Prof. Hugh Willison in Glasgow, UK.